DORCHESTER WEALTH MANAGEMENT Co reduced its position in UnitedHealth Group Inc (NYSE:UNH) by 4.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 14,895 shares of the healthcare conglomerate’s stock after selling 720 shares during the quarter. UnitedHealth Group makes up about 1.3% of DORCHESTER WEALTH MANAGEMENT Co’s investment portfolio, making the stock its 29th biggest holding. DORCHESTER WEALTH MANAGEMENT Co’s holdings in UnitedHealth Group were worth $3,711,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently made changes to their positions in UNH. Ipswich Investment Management Co. Inc. acquired a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $40,000. Contravisory Investment Management Inc. lifted its position in UnitedHealth Group by 172.1% in the fourth quarter. Contravisory Investment Management Inc. now owns 185 shares of the healthcare conglomerate’s stock worth $46,000 after purchasing an additional 117 shares during the period. IMS Capital Management acquired a new stake in UnitedHealth Group in the third quarter worth approximately $85,000. CX Institutional lifted its position in UnitedHealth Group by 475.0% in the fourth quarter. CX Institutional now owns 322 shares of the healthcare conglomerate’s stock worth $80,000 after purchasing an additional 266 shares during the period. Finally, Worth Venture Partners LLC acquired a new stake in UnitedHealth Group in the third quarter worth approximately $104,000. 90.80% of the stock is owned by hedge funds and other institutional investors.
NYSE:UNH traded up $0.30 during trading hours on Wednesday, hitting $263.80. 3,066,428 shares of the stock traded hands, compared to its average volume of 3,853,503. The company has a quick ratio of 0.69, a current ratio of 0.73 and a debt-to-equity ratio of 0.64. UnitedHealth Group Inc has a fifty-two week low of $212.49 and a fifty-two week high of $287.94. The company has a market cap of $251.96 billion, a P/E ratio of 20.48, a price-to-earnings-growth ratio of 1.34 and a beta of 0.86.
UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, January 15th. The healthcare conglomerate reported $3.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.20 by $0.08. UnitedHealth Group had a net margin of 5.30% and a return on equity of 24.38%. The company had revenue of $58.42 billion for the quarter, compared to the consensus estimate of $58.01 billion. During the same period in the previous year, the business earned $2.59 EPS. The company’s revenue was up 12.2% on a year-over-year basis. Equities research analysts anticipate that UnitedHealth Group Inc will post 14.62 earnings per share for the current year.
A number of research firms have weighed in on UNH. BMO Capital Markets upped their target price on UnitedHealth Group to $310.00 and gave the stock an “outperform” rating in a research report on Thursday, October 18th. Cantor Fitzgerald restated a “buy” rating and issued a $310.00 target price on shares of UnitedHealth Group in a research report on Wednesday, November 21st. Piper Jaffray Companies upped their target price on UnitedHealth Group to $300.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 17th. Stephens began coverage on UnitedHealth Group in a research report on Monday, January 14th. They issued an “overweight” rating and a $287.00 target price for the company. Finally, Raymond James upped their target price on UnitedHealth Group from $304.00 to $310.00 and gave the stock a “strong-buy” rating in a research report on Wednesday, October 17th. One investment analyst has rated the stock with a hold rating and twenty-two have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $297.80.
In other UnitedHealth Group news, Director Richard T. Burke sold 15,000 shares of the stock in a transaction on Thursday, January 17th. The shares were sold at an average price of $260.55, for a total transaction of $3,908,250.00. Following the transaction, the director now directly owns 193,872 shares of the company’s stock, valued at $50,513,349.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director William C. Ballard, Jr. sold 5,000 shares of the stock in a transaction on Tuesday, January 22nd. The stock was sold at an average price of $266.61, for a total transaction of $1,333,050.00. Following the transaction, the director now directly owns 77,702 shares in the company, valued at $20,716,130.22. The disclosure for this sale can be found here. Insiders sold 26,090 shares of company stock worth $6,956,975 over the last ninety days. 0.87% of the stock is currently owned by company insiders.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children’s Health Insurance Program, and health care programs; and health and dental benefits.
See Also: Federal Reserve
Receive News & Ratings for UnitedHealth Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.